EpiFix has demonstrated in previous studies very high rates of healing, with the original study showing 90%+ rates of healing in DFU wounds and 71% in VLU wounds.
With studies looking at long term follow up and the overall time to closure using weekly applications v biweekly, MiMedx demonstrates the effectiveness of EpiFix in hard to heal/non-healing ulcers.
The latest study further demonstrates this in a wider group of patients across multiple centres:
This further adds to the existing evidence for the use of Amniotic Tissue in wound healing and justification of advanced therapies in hard to heal and non healing wounds,
Multicentre RCT on DFU: